# Rheumatology Live

> Rheumatology Live - Healthcare Publication

- Base URL: https://www.rheum-live.com
- Generated: 2026-10-21T03:19:59.506Z
- Content updates: multiple times daily

## Content Access for AI Agents

This site supports content negotiation for AI/LLM consumption. Request any article URL with an appropriate Accept header to receive structured content instead of HTML.

**Supported content types:**
- `text/markdown` — Clean Markdown with YAML frontmatter
- `text/plain` — Plain text (same as Markdown)
- `text/html` — Default HTML response

**Example request:**
```
curl -H "Accept: text/markdown" https://www.rheum-live.com/view/article-slug
```

**YAML frontmatter schema** (returned with every Markdown response):

| Field | Type | Description |
|-------|------|-------------|
| `title` | string | Article headline |
| `description` | string | Summary/excerpt (max 300 chars) |
| `url` | string | Canonical article URL |
| `canonical_url` | string | Canonical URL if different from `url` |
| `published` | ISO 8601 | Original publication date |
| `modified` | ISO 8601 | Last modification date |
| `authors` | string[] | Author display names |
| `content_type` | string | Content category (e.g., "News", "Clinical") |
| `categories` | string[] | Taxonomy categories |
| `tags` | string[] | SEO tags |
| `image` | string | Featured image URL |
| `publisher` | string | Publication/site name |

**Discovery headers** (included on all responses):
- `Link: <https://www.rheum-live.com/llms.txt>; rel="llms"` — RFC 8288 link to this file
- `X-Llms-Txt: https://www.rheum-live.com/llms.txt` — Explicit discovery header

## Usage Policy

- Robots policy: [https://www.rheum-live.com/robots.txt](https://www.rheum-live.com/robots.txt)
- Cache behavior: responses are cached for ~5 minutes (max-age=300, stale-while-revalidate=329)
- Rate guidance: prefer RSS and sitemap feeds over crawling individual pages
- Attribution: All content © MJH Life Sciences. Include source URLs when citing.

## Content Categories

- [Clinical](https://www.rheum-live.com/clinical)
- [Conference](https://www.rheum-live.com/conference)
- [News](https://www.rheum-live.com/news)
- [Peer Exchange](https://www.rheum-live.com/peer-exchange)
- [Peers Perspectives](https://www.rheum-live.com/peers-perspectives)
- [Physician's Money Digest](https://www.rheum-live.com/physicians-money-digest)
- [Podcasts](https://www.rheum-live.com/podcasts)
- [Rheumatology](https://www.rheum-live.com/clinical)
- [Sponsored Resources](https://www.rheum-live.com/sponsored-resources)
- [Strategic Alliance Partnership](https://www.rheum-live.com/sap-partner)
- [Video Series](https://www.rheum-live.com/video-series)
- [Videos](https://www.rheum-live.com/videos)

## Featured Content

- [FDA Approves Cevimeline Oral Solution for Dry Mouth in Sjögren Disease](https://www.rheum-live.com/view/fda-approves-cevimeline-oral-solution-for-dry-mouth-in-sjogren-disease): The new 30-mg/5-mL formulation offers an alternative for adults who have difficulty swallowing capsules. 
- [GLP-1 Agonists: From the Scale to the Joint in Arthritis](https://www.rheum-live.com/view/glp-1-agonists-scale-to-joint-arthritis): On World Arthritis Day, TOGETHER-PsA data and 3 rheumatology/derm experts frame GLP-1 agonists as a promising — but not yet proven — adjunct therapy.
- [Ixekizumab-Tirzepatide Sustains 1-Year Gains in Psoriatic Disease, Obesity](https://www.rheum-live.com/view/ixekizumab-tirzepatide-sustains-1-year-gains-psoriatic-disease-obesity): At Week 52, ixekizumab plus tirzepatide sustained gains in skin clearance, joint response and metabolic measures versus ixekizumab alone.
- [Clinical Pearls for Nutrition and Weight Loss in PsA](https://www.rheum-live.com/view/clinical-pearls-for-nutrition-and-weight-loss-in-psa): Protein intake, pacing weight loss safely, and remembering that one patient in front of you has one life to live round out a rheumatologist's closing...
- [AMETHYST: Litifilimab Sustains CLE Gains at 52 Weeks, With Victoria Werth, MD](https://www.rheum-live.com/view/amethyst-litifilimab-sustains-cle-gains-at-52-weeks-werth): Werth discusses what the 52-week AMETHYST Part A data add to the case for litifilimab in antimalarial-refractory cutaneous lupus erythematosus.
- [Practical Advice for Patients Starting Incretin-Biologic Therapy](https://www.rheum-live.com/view/practical-advice-for-patients-starting-incretin-biologic-therapy): A clinician's dosing and nutrition guidance meets a patient's hard-won advice for anyone entering combination therapy: manage expectations, stay engag...
- [Emerging Research and Reduction in Medication Use with Combination PsA Care](https://www.rheum-live.com/view/emerging-research-and-reduction-in-medication-use-with-combination-psa-care): Dr. Bakewell and Dr. Perkins highlight new ongoing studies in PsA care and a shrinking medication list with combination approach.
- [NovoBioJect Boosts Active Methotrexate Levels in Phase 1b RA Trial](https://www.rheum-live.com/view/novobioject-boosts-active-methotrexate-levels-phase-1b-ra-trial): Amplio Pharma now planning a phase 2a study after NovoBioJect raised intracellular active methotrexate levels by 38%.
- [Mental Health, Comorbidities, and PsA Combination Therapy Trials](https://www.rheum-live.com/view/mental-health-comorbidities-and-psa-combination-therapy-trials): Beyond joint counts and skin scores, the panel examines how combination therapy touched a veteran's mental health, and where cardiac, cognitive, and o...
- [Adding an Incretin Therapy to a Biologic for PsA: TOGETHER-PsA Trial](https://www.rheum-live.com/view/adding-an-incretin-therapy-to-a-biologic-for-psa-together-psa-trial): Casual observations about benefits of incretin therapy in patients with psoriatic diseases lead to combination therapy approach and TOGETHER-PsA trial...

## Feeds and Indexes

- [RSS Feed](https://www.rheum-live.com/rss.xml): Latest articles in XML syndication format
- [Sitemap](https://www.rheum-live.com/sitemap.xml): Complete URL index for all published pages
- [News Sitemap](https://www.rheum-live.com/sitemap-news.xml): Recent articles optimized for news indexing
- [Authors Directory](https://www.rheum-live.com/authors): Browse all contributors and their published work